Benson walks into a hostage situation at a neighborhood restaurant. Rollins tries to help her father after he's hospitalized. Guest starring Sarita Choudhury and James Morrison.
Benson walks into a hostage situation at a neighborhood restaurant. Rollins tries to help her father after he's hospitalized. Guest starring Sarita Choudhury and James Morrison.
Rod Brind’Amour, in his first three years at the helm, is the first to lead the Hurricanes to three straight playoff appearances. He has his sights set on another Cup run.
MNP, one of Canada's largest national accounting, tax and business consulting firms, is pleased to announce that it will join forces with DMK Chartered Professional Accountants ('DMK'), effective July 1, 2021.
First Student, the largest student transportation provider in North America, and the Lion Electric Company (NYSE: LEV) (TSX: LEV) ("Lion" or the "Company"), a leading manufacturer of all-electric medium and heavy-duty urban vehicles, today jointly announced that First Student is ordering 260 all-electric LionC school buses.
Stem, Inc. (NYSE:STEM) announces financial results for the first quarter ended March 31, 2021.
Bitcoin stabilized around $45,000 after Tesla CEO Elon Musk clarified the firm would not be selling its holdings.
Singapore’s 11th integrated transport hub (ITH), Woodlands ITH, will open on 13 June, the Land Transport Authority (LTA) said on Monday (17 May).
The "Saudi Arabia Ready Meals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Liquid Dietary Supplements Market by Ingredient, Application, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The liquid dietary supplements market accounted for $21,685.72 million in 2019, and is expected to reach $27,732.27 million by 2027, registering a CAGR of 4.0% from 2020 to 2027.Liquid dietary supplements are nutritional supplements that are available in fluid form. They are usually consumed to enhance body metabolism and reduce occurrences of lifestyle disorders. Liquid dietary supplements are largely used by consumers that are unable to consume dietary supplements in capsule, thick gel, and solid tablet forms.According to the consumer survey of Council for Responsible Nutrition's (CRN), more than 70% women in the U.S. (around 113 million female consumers) prefer taking supplements on regular basis. The same survey reveals that top concerns for taking dietary supplements such as overall wellness accounts for 57%, bone health for 31% and healthy aging for 27%. Along with prominent shift of society toward preventive and healthier lifestyle, coupled with growth in consumers including children and aged population, choosing nutrition supplements in their daily routines are expected to propel growth of the global liquid dietary supplements market. However, fake product marketing and violation of regulations regarding label of products are anticipated to restrain growth of the liquid dietary supplements market.Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as presence of major market players in this region, which are introducing quality products to capture maximum market share. In addition, government support for research & development and availability of funds for research fuel the market growth. Moreover, the U.S. is the target area for top players in the market, owing to high awareness regarding dietary supplements devices. However, Asia-Pacific and LAMEA are expected to emerge as lucrative areas with maximum growth potential, owing to investments in new inventions, general economic conditions, increase in number of athletes and sports professionals, increase in the economy, and rise in health risks and diseases, which can be controlled by consumption of dietary supplements.The global liquid dietary supplements market is segmented on the basis of ingredient, application, distribution channel, and region. On the basis of ingredient, it is categorized into vitamins & minerals, botanical, proteins & amino acids and others. On the basis of application, it is categorized into bone & joint health, heart health, immune health, sports nutrition, weight loss, and others. On the basis of distribution channel, it is categorized into hypermarkets/supermarkets, health & beauty retail stores, drug stores, and online pharmacies & e-commerce sites. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).The key companies operating in the market include Abbott Laboratories, Bayer, Herbalife International, Koninklijke DSM, BASF, DuPont Nutrition & Biosciences, GlaxoSmithKline, Amway, Glanbia, Liquid Health, Inc.Key Benefits The study provides an in-depth analysis of the global liquid dietary supplements market along with the current trends and future estimations to elucidate the imminent investment pockets.It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.The key market players and their strategies have been analyzed to understand the competitive outlook of the global liquid dietary supplements market. Key Topics Covered: Chapter 1: Introduction Chapter 2: Executive Summary2.1. Key Findings of the Study2.2. Cxo PerspectiveChapter 3: Market Overview3.1. Market Definition and Scope3.2. Key Findings3.2.1. Top Player Positioning3.2.2. Top Investment Pockets3.2.3. Top Winning Strategies3.3. Porter's Five Forces Analysis3.4. Impact Analysis3.4.1. Drivers188.8.131.52. Healthy Aging and Proactive Consumption of Nutritional Interventions184.108.40.206. Rise in Adoption of Rtd (Ready-To-Drink) Dietary Supplements3.4.2. Restraint220.127.116.11. Stringent Rules and Regulations3.4.3. Opportunity18.104.22.168. High Growth Potential in Emerging Markets3.5. Impact of COVID-19 on Liquid Dietary Supplements MarketChapter 4: Liquid Dietary Supplements Market, by Ingredient4.1. Overview4.1.1. Market Size and Forecast4.2. Vitamins & Minerals4.2.1. Key Market Trends and Opportunities4.2.2. Market Size and Forecast, by Region4.3. Botanical4.3.1. Key Market Trends and Opportunities4.3.2. Market Size and Forecast, by Region4.4. Proteins & Amino Acids4.4.1. Key Market Trends and Opportunities4.4.2. Market Size and Forecast, by Region4.5. Others4.5.1. Key Market Trends and Opportunities4.5.2. Market Size and Forecast, by RegionChapter 5: Liquid Dietary Supplements Market, by Application5.1. Overview5.1.1. Market Size and Forecast5.2. Bone & Joint Health5.2.1. Key Market Trends and Opportunities5.2.2. Market Size and Forecast, by Region5.2.3. Market Analysis, by Country5.3. Heart Health5.3.1. Key Market Trends and Opportunities5.3.2. Market Size and Forecast, by Region5.3.3. Market Analysis, by Country5.4. Immune Health5.4.1. Key Market Trends and Opportunities5.4.2. Market Size and Forecast, by Region5.4.3. Market Analysis, by Country5.5. Sports Nutrition5.5.1. Key Market Trends and Opportunities5.5.2. Market Size and Forecast, by Region5.5.3. Market Analysis, by Country5.6. Weight Loss5.6.1. Key Market Trends and Opportunities5.6.2. Market Size and Forecast, by Region5.6.3. Market Analysis, by Country5.7. Digestive Health5.7.1. Key Market Trends and Opportunities5.7.2. Market Size and Forecast, by Region5.7.3. Market Analysis, by Country5.8. Others5.8.1. Key Market Trends and Opportunities5.8.2. Market Size and Forecast, by Region5.8.3. Market Analysis, by CountryChapter 6: Liquid Dietary Supplements Market, by Distribution Channel6.1. Overview6.1.1. Market Size and Forecast6.2. Hypermarket/Supermarket6.2.1. Market Size and Forecast, by Region6.2.2. Market Analysis, by Country6.3. Health and Beauty Retail Stores6.3.1. Market Size and Forecast, by Region6.3.2. Market Analysis, by Country6.4. DrU.S.ores6.4.1. Market Size and Forecast, by Region6.4.2. Market Analysis, by Country6.5. Online Pharmacies and E-Commerce Sites6.5.1. Market Size and Forecast, by Region6.5.2. Market Analysis, by CountryChapter 7: Liquid Dietary Supplements Market, by Region7.1. Overview7.2. North America7.3. Europe7.4. Asia-Pacific7.5. LAMEAChapter 8: Company Profiles8.1. Abbott Laboratories8.1.1. Company Overview8.1.2. Company Snapshot8.1.3. Operating Business Segments8.1.4. Product Portfolio8.1.5. Key Strategic Moves and Developments8.2. Bayer8.2.1. Company Overview8.2.2. Company Snapshot8.2.3. Operating Business Segments8.2.4. Product Portfolio8.3. Herbalife International8.3.1. Company Overview8.3.2. Company Snapshot8.3.3. Operating Business Segments8.3.4. Product Portfolio8.4. Koninklijke Dsm8.4.1. Company Overview8.4.2. Company Snapshot8.4.3. Operating Business Segments8.4.4. Product Portfolio8.4.5. Business Performance8.4.6. Key Strategic Moves and Developments8.5. Basf8.5.1. Company Overview8.5.2. Company Snapshot8.5.3. Operating Business Segments8.5.4. Product Portfolio8.5.5. Key Strategic Moves and Developments8.6. Dupont Nutrition & Biosciences8.6.1. Company Overview8.6.2. Company Snapshot8.6.3. Operating Business Segments8.6.4. Product Portfolio8.6.5. Business Performance8.7. GlaxoSmithKline8.7.1. Company Overview8.7.2. Company Snapshot8.7.3. Operating Business Segments8.7.4. Product Portfolio8.7.5. Business Performance8.8. Amway8.8.1. Company Overview8.8.2. Company Snapshot8.8.3. Operating Business Segments8.8.4. Product Portfolio8.8.5. Business Performance8.9. Glanbia8.9.1. Company Overview8.9.2. Company Snapshot8.9.3. Operating Business Segments8.9.4. Product Portfolio8.10. Liquid Health, Inc.8.10.1. Company Overview8.10.2. Company Snapshot8.10.3. Operating Business Segments8.10.4. Product PortfolioFor more information about this report visit https://www.researchandmarkets.com/r/9efk3v CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Injection Molding Machine Market Research Report by Product Type (Metal, Plastic, and Rubber), by Machine Type (All-Electric Injection Molding Machine, Hybrid Injection Molding Machine, and Hydraulic Injection Molding Machine), by Clamping Force, by End-Use Industry - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, May 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Injection Molding Machine Market Research Report by Product Type, by Machine Type, by Clamping Force, by End-Use Industry - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06073668/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Injection Molding Machine Market is expected to grow from USD 9,823.64 Million in 2020 to USD 12,174.39 Million by the end of 2025.2. The Global Injection Molding Machine Market is expected to grow from EUR 8,613.55 Million in 2020 to EUR 10,674.73 Million by the end of 2025.3. The Global Injection Molding Machine Market is expected to grow from GBP 7,657.46 Million in 2020 to GBP 9,489.86 Million by the end of 2025.4. The Global Injection Molding Machine Market is expected to grow from JPY 1,048,431.31 Million in 2020 to JPY 1,299,315.91 Million by the end of 2025.5. The Global Injection Molding Machine Market is expected to grow from AUD 14,265.23 Million in 2020 to AUD 17,678.83 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Injection Molding Machine to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Product Type, the Injection Molding Machine Market studied across Metal, Plastic, and Rubber. The Metal further studied across Ceramic, Liquid, and Powder. The Plastic further studied across Rubber, Thermoplastics, and Thermosets. Based on Machine Type, the Injection Molding Machine Market studied across All-Electric Injection Molding Machine, Hybrid Injection Molding Machine, and Hydraulic Injection Molding Machine. Based on Clamping Force, the Injection Molding Machine Market studied across 0-200 Ton-Force, 201-500 Ton-Force, and Above 500 Ton-Force. Based on End-Use Industry, the Injection Molding Machine Market studied across Automotive, Consumer Goods, Electrical & Electronics, Healthcare, and Packaging. Based on Geography, the Injection Molding Machine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Injection Molding Machine Market including Arburg GmbH & Co. Kg, Boco Pardubice Machines S.R.O., Borche North America Inc., Chen Hsong Holdings Limited, Dongshin Hydraulic Co. Ltd., Dr. Boy GmbH & Co. Kg, Engel Austria Gmbh, Fu Chun Shin Machinery Manufacture Co. Ltd., Haitian International Holdings Limited, Hillenbrand, Inc., Huarong Plastic Machinery Co. Ltd., Husky Injection Molding Systems Ltd., Kraussmaffei Group Gmbh, Mitsubishi Heavy Industries Plastic Technology Co. Ltd., Mold Hotrunner Solutions Ltd., Multiplas Enginery Co. Ltd., Niigata Machine Techno Company, Ltd., Nissei Plastic Industrial Co. Ltd., Oima SRL, R.P. Injection Srl, Shibaura Machine (Toshiba Machine Co. Ltd.), SMF Maschinenfabrik Gmbh, Sumitomo Heavy Industries Limited, The Japan Steel Works Ltd., Toyo Machinery & Metal Co. Ltd., and Woojin Plaimm Co. Ltd.. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Injection Molding Machine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Injection Molding Machine Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Injection Molding Machine Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Injection Molding Machine Market?4. What is the competitive strategic window for opportunities in the Global Injection Molding Machine Market?5. What are the technology trends and regulatory frameworks in the Global Injection Molding Machine Market?6. What are the modes and strategic moves considered suitable for entering the Global Injection Molding Machine Market?Read the full report: https://www.reportlinker.com/p06073668/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
British holidaymakers returned to Portugal on Monday as the country seeks to revive its battered tourism industry after lifting travel restrictions that had been imposed to curb Covid-19.
The market rally remains tricky, but ASML and Google are in buy zones. Beware false leaders like Apple. Bitcoin broke below key support on fresh comments from Elon Musk.
Holidaymakers from England, Scotland and Wales are now able to jet off for some early summer sun.
Phoenix, AZ, May 17, 2021 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) reported Fiscal 2021 revenues of approximately $4.203 million for the Fiscal Year Ended January 31, 2021 compared to revenues of approximately $6.568 million for the same prior year period. Basic earnings per share for Fiscal Year ended January 31, 2021 was ($0.31) compared with ($0.21) for the Fiscal Year ended January 31, 2020. This decline was largely attributable to the negative impact of the Covid-19 virus pandemic. Economic conditions improved for the Trust, however, in Q4 compared to Q3 of Fiscal Year 2021. Fiscal 2021 fourth quarter revenues remained approximately flat for the three-month period of November 1, 2020 to January 31, 2021, compared to revenues for Q3 of Fiscal Year 2021. A number of areas of our hotel operations are off to a solid start in the current 2022 Fiscal Year, ending January 31, 2022. In 2019, InnSuites Hospitality Trust (IHT) made an initial $1 million diversification investment in privately held UniGen Power, Inc. (UniGen), a company developing a patented high profit potential efficient clean energy generation innovation. The UniGen innovation is quite promising, as evidenced by UPI’s current pursuit of three more valuable patents. In addition to the initial investment, which could be converted into 1 million UPI shares, IHT also holds warrants that, if fully converted, would issue to IHT some 2 million additional UniGen shares, which in the aggregate could result in IHT holding up to an approximate 25% ownership stake in UniGen. IHT is informed that UniGen has made positive progress to date on development of this innovation, with the first two Prototypes scheduled to be operational later this year. Said James Wirth President, CEO, and Board Chairman: “The Fiscal Year 2021 just ended reflects the effects of the one-time extraordinary Covid-19 Virus, and its overall impact on the Hotel and Travel Industry, not to mention the entire national and global economy. IHT continues to execute our strategic plan of selling existing hotel real estate at market prices significantly above our carrying (book) values, and moving toward diversification, including IHT’s high potential investment in UniGen’s innovative efficient, clean-energy power generation innovation, a positive move that is increasingly recognized by investors.” As investors increasingly recognize the potential of the UniGen diversification clean energy efficient innovation, trading volume of IHT has increased. Management believes in the substantial potential ahead of the UniGen project, as it continues on course. For more information, visit www.innsuitestrust.com and www.innsuites.com. Forward-Looking Statements With the exception of historical information, matters discussed in this news release may include “forward-looking statements” within the meaning of the federal securities laws. All statements regarding IHT’s review and exploration of potential strategic, operational and structural alternatives and expected associated costs and benefits are forward-looking. Actual developments and business decisions may differ materially from those expressed or implied by such forward-looking statements. Important factors, among others, that could cause IHT’s actual results and future actions to differ materially from those described in forward-looking statements include the uncertain outcome, impact, effects and results of IHT’s review of strategic, operational and structural alternatives, IHT’s success in finding potential qualified purchasers for its hospitality real estate, or a reverse merger partner, the success of and timing of the UniGen clean energy innovation, and other risks discussed in IHT’s SEC filings. IHT expressly disclaims any obligation to update any forward-looking statement contained in this news release to reflect events or circumstances that may arise after the date hereof, all of which are expressly qualified by the foregoing, other than as required by applicable law. FOR FURTHER INFORMATION: Marc Berg, Executive Vice President 602-944-1500 email: firstname.lastname@example.org INNSUITES HOTEL CENTRE1730 E. NORTHERN AVENUE, #122Phoenix, Arizona 85020Phone: 602-944-1500
17 May 2021Announcement no. 322 Interim Management Statement covering Q3 2020/21 The Board of Directors of Rovsing A/S has today considered and approved the Interim Management Statement for the third quarter (1 January 2021 – 31 March 2021) of the financial year 2020/21. Q3 highlights In Q3 of the financial year 2020/21, the revenue amounted to DKK 7,6 million (2019/20: DKK 6,2 million). Accumulated year to date revenue is DKK 20,0 million.Q3 EBITDA of DKK 0,9 million (2019/20: DKK 0,5 million). Accumulated year to date EBITDA of DKK 1,9 million. Rovsing has achieved key milestones with its Customers in Q3 2020/21, kicking off the FLEX Electrical Power Subsystem (EPS) Electrical Ground Support Equipment (EGSE) for Thales Alenia Space in the UK and the Mars Sample Return-Earth Return Orbiter (MSR-ERO) Electrical-Satellite Interface Simulator (E-SIS) for Airbus DS in Toulouse as well as finalizing the Test Readiness Review on the PLATO EPS SCOE for Thales Alenia Space in the UK to name a few key milestones. Rovsing’s market position within the segment has been further strengthened based on the delivered performance and value. Reflecting Rovsing position as an important key provider on major ongoing ESA missions, delivering test- and simulation systems, individual products, software solutions, ISVV and on-site engineering services. The order intake in year to date of 2020/21 is DKK 20,2 million and the order backlog (exclusive of ongoing service contracts) at 31 March 2021 is DKK 15,5 million. The projected industry pipeline is at a higher level compared to recent years, which reflects the market growth with many ongoing and upcoming institutional and commercial space programmes. The related order backlog for Rovsing gives as well a positive operational outlook for the coming years. Due to this development Rovsing has added three additional hires in May and April.The guided outlook for the financial year 2020/21 is maintained with a revenue in a range of DKK 27 to 29 million and an EBITDA in the range of DKK 2,5 to 3,5 million. Further information Hjalti Pall Thorvardarson, CEO. Email: email@example.com Tel. +45 53 39 18 88 Attachment Announcement322_Interim_Q2-2020-21_final
Sheffield Doc/Fest, the key UK documentary event, has revealed its full line-up for this year, including an international competition comprised of 11 features. Those titles are: Charm Circle by Nira Burstein (USA, World Premiere); Rancho by Pedro Speroni (Argentina, World Premiere); Factory to the Workers by Srđan Kovačević (Croatia, World Premiere); Summer by Vadim Kostrov […]
An Israeli air strike killed a top commander with the Islamic Jihad militant group in Gaza on Monday, the Israeli military and a source in the group said. The killing of Hussam Abu Harbeed, Islamic Jihad's northern division commander, was likely to draw a fierce response from the militant group as Israel's fighting also rages on with the enclave's Islamist rulers Hamas. In a statement confirming it had killed Harbeed, the Israeli military said he "was behind several anti-tank missile terror attacks against Israeli civilians."
(Bloomberg) -- The Tokyo Stock Exchange is considering expanding trading hours for cash equities in a move designed to attract retail investors and foreign traders, the Nikkei newspaper reported, without citing anyone.The bourse, which currently ends trading at 3 p.m. Tokyo time, is considering expanding hours into the afternoon or evening in a change that could be in time for a system renewal in 2024, the report said. An advisory body plans to meet as early as this week and solicit opinions from brokerages and institutional investors, according to the Nikkei.If realized, the move would be the first significant change in trading hours in Tokyo in over a decade. In 2011, the exchange shortened its lunch break by 30 minutes to the current one hour. The Tokyo exchange now trades between 9 a.m. and 3 p.m. local time, with the break between 11:30 a.m. and 12:30 p.m., making the five-hour trading day considerably shorter than many other regional rivals. The bourse is also considering canceling the fixed lunch break, the Nikkei said.A spokesman for Japan Exchange Group Inc., which operates the TSE, said it wasn’t the source of the report.“Compared to overseas markets, trading hours for Japanese stocks is limited,” said Masahiro Ichikawa, chief market strategist at Sumitomo Mitsui DS Asset Management Co. An extension “will make it easier to draw in foreign investors. It will also make it an easier environment for domestic investors, including retail investors, to trade.”The move is likely to face local opposition, however. A similar recommendation in 2014 for the exchange to consider an evening session failed to pass, with plans dropped following opposition from traditional brokerages who said longer hours would increase costs. Some members of an advisory panel at the time also called for a separate afternoon session.“If really implemented, this would require a lot of adjustments from both front-end to back,” Takeo Kamai, head of execution services at CLSA Securities Japan Co., said. “We’ll really need to see how much support this idea will get from the street.”With most companies reporting earnings after the close of market, trading is often done on exchanges overseas, or on proprietary trading systems (PTS) run by securities firm, such as the SBI Holdings Inc.-backed Japannext Co.Averting Outages, Topix Rejig Key Tests for New Tokyo Bourse CEOThere has been renewed interest in such alternative venues since the TSE’s unprecedented outage last October, which highlighted how centralizing trading in Japan is. In March, Cboe Global Markets Inc. agreed to acquire Chi-X Asia Pacific Holdings Ltd. to expand its reach into Japan and other markets. A growth in rival venues could be a threat to the Tokyo exchange, though recently appointed CEO Hiromi Yamaji has said he welcomed the competition.(Updates with details throughout)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Insurance Brokerage Market By Insurance Type and Brokerage Type: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. An insurance broker is an intercessor who sells, asks, or negotiates for insurance policies on behalf of their clients with multiple insurers. An insurance broker is completely different from an insurance agent. It is advisable to consumers and business owners to go for insurance policies through broker rather than on own because brokers have the experience to guide their clients to the right policies with the proper level of coverage. Furthermore, digital platforms are being deployed by insurance brokerage firms for brand promotion and trust-building in a competitive market. Insurance brokers need to educate themselves about technology in order to essentially evolve their role as experts and trusted advisors who foresee and minimize risks. In this way insurance broker can play a balancing role between physical clients and digital technologies.Increased demand for insurance policies, integration of IT & analytic solutions, and providing professional solutions and services are the major factors that drive the growth of the global insurance brokerage market. Moreover, direct purchases of insurance policies by customers and massive availability of alternative platforms for purchasing insurance policy hamper the growth of the market. Furthermore, implementation of technologies in existing products and service lines and government initiatives regarding insurance policies are expected to provide lucrative opportunity for the market expansion during the forecast period.The global insurance brokerage market is segmented on the basis of insurance type, brokerage type, and region. In terms of types, it is fragmented into life insurance and P&C insurance. Depending on brokerage type, it is bifurcated into retail brokerage and wholesale brokerage. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.The key players profiled in the insurance brokerage market report are Acrisure, LLC, Aon plc, Brown & Brown, Inc, Gallagher, HUB International Limited, Lockton companies, Marsh & McLennan Companies Inc., Truist Insurance Holdings, USI Insurance Services L.L.C, and Willis Towers Watson. These players have adopted various strategies to increase their market penetration and strengthen their position in the industry.Key Benefits For Stakeholders The study provides an in-depth analysis of the global insurance brokerage market along with the current trends and future estimations to elucidate the imminent investment pockets.Information about key drivers, restraints, and opportunities and their impact analysis on the global insurance brokerage market size is provided in the report.Porter's five forces analysis illustrates the potency of the buyers and suppliers operating in the industry.The quantitative analysis of the market from 2019 to 2027 is provided to determine the market potential. Key Topics Covered: Chapter 1: Introduction1.1. Report Description1.2. Key Market Segments1.3. Key Benefits1.4. Research Methodology1.4.1. Primary Research1.4.2. Secondary Research1.4.3. Analyst Tools and ModelsChapter 2: Executive Summary2.1. Cxo PerspectiveChapter 3: Market Landscape3.1. Market Definition and Scope3.2. Key Findings3.2.1. Top Investment Pockets3.2.2. Top Winning Strategies3.3. Porter's Five Forces Analysis3.3.1. Bargaining Power of Suppliers3.3.2. Threat of New Entrants3.3.3. Threat of Substitutes3.3.4. Competitive Rivalry3.3.5. Bargaining Power Among Buyers3.4. Market Share Analysis/Top Player Positioning 20193.5. Market Dynamics3.5.1. Drivers3.5.2. Restraints3.5.3. OpportunitiesChapter 4: Insurance Brokerage Market by Insurance Type4.1. Overview4.2. Life Insurance4.2.1. Key Market Trends, Growth Factors and Opportunities4.2.2. Market Size and Forecast, by Region4.2.3. Market Share Analysis, by Country4.3. Property and Casualty Insurance4.3.1. Key Market Trends, Growth Factors and Opportunities4.3.2. Market Size and Forecast, by Region4.3.3. Market Share Analysis, by CountryChapter 5: Insurance Brokerage Market by Brokerage Type5.1. Overview5.2. Retail Brokerage5.2.1. Key Market Trends, Growth Factors and Opportunities5.2.2. Market Size and Forecast, by Region5.2.3. Market Share Analysis, by Country5.3. Wholesale Brokerage5.3.1. Key Market Trends, Growth Factors and Opportunities5.3.2. Market Size and Forecast, by Region5.3.3. Market Share Analysis, by CountryChapter 6: Insurance Brokerage Market by Region6.1. Overview6.2. North America6.2.1. Key Market Trends and Opportunities6.2.2. Market Size and Forecast, by Insurance Type6.2.3. Market Size and Forecast, by Brokerage Type6.2.4. Market Size and Forecast, by Country6.2.5. US22.214.171.124. Market Size and Forecast, by Insurance Type126.96.36.199. Market Size and Forecast, by Brokerage Type6.2.6. Canada188.8.131.52. Market Size and Forecast, by Insurance Type184.108.40.206. Market Size and Forecast, by Brokerage Type6.3. Europe6.3.1. Key Market Trends and Opportunities6.3.2. Market Size and Forecast, by Insurance Type6.3.3. Market Size and Forecast, by Brokerage Type6.3.4. Market Size and Forecast, by Country6.3.5. Germany220.127.116.11. Market Size and Forecast, by Insurance Type18.104.22.168. Market Size and Forecast, by Brokerage Type6.3.6. France22.214.171.124. Market Size and Forecast, by Insurance Type126.96.36.199. Market Size and Forecast, by Brokerage Type6.3.7. UK188.8.131.52. Market Size and Forecast, by Insurance Type184.108.40.206. Market Size and Forecast, by Brokerage Type6.3.8. Italy220.127.116.11. Market Size and Forecast, by Insurance Type18.104.22.168. Market Size and Forecast, by Brokerage Type6.3.9. Spain22.214.171.124. Market Size and Forecast, by Insurance Type126.96.36.199. Market Size and Forecast, by Brokerage Type6.3.10. Rest of Europe188.8.131.52. Market Size and Forecast, by Insurance Type184.108.40.206. Market Size and Forecast, by Brokerage Type6.4. Asia-Pacific6.4.1. Key Market Trends and Opportunities6.4.2. Market Size and Forecast, by Insurance Type6.4.3. Market Size and Forecast, by Brokerage Type6.4.4. Market Size and Forecast, by Country6.4.5. China220.127.116.11. Market Size and Forecast, by Insurance Type18.104.22.168. Market Size and Forecast, by Brokerage Type6.4.6. Japan22.214.171.124. Market Size and Forecast, by Insurance Type126.96.36.199. Market Size and Forecast, by Brokerage Type6.4.7. India188.8.131.52. Market Size and Forecast, by Insurance Type184.108.40.206. Market Size and Forecast, by Brokerage Type6.4.8. Australia220.127.116.11. Market Size and Forecast, by Insurance Type18.104.22.168. Market Size and Forecast, by Brokerage Type6.4.9. South Korea22.214.171.124. Market Size and Forecast, by Insurance Type126.96.36.199. Market Size and Forecast, by Brokerage Type6.4.10. Singapore188.8.131.52. Market Size and Forecast, by Insurance Type184.108.40.206. Market Size and Forecast, by Brokerage Type6.4.11. Rest of Asia-Pacific220.127.116.11. Market Size and Forecast, by Insurance Type18.104.22.168. Market Size and Forecast, by Brokerage Type6.5. LAMEA6.5.1. Key Market Trends and Opportunities6.5.2. Market Size and Forecast, by Insurance Type6.5.3. Market Size and Forecast, by Brokerage Type6.5.4. Market Size and Forecast, by Country6.5.5. Latin America22.214.171.124. Market Size and Forecast, by Insurance Type126.96.36.199. Market Size and Forecast, by Brokerage Type6.5.6. Middle East188.8.131.52. Market Size and Forecast, by Insurance Type184.108.40.206. Market Size and Forecast, by Brokerage Type6.5.7. Africa220.127.116.11. Market Size and Forecast, by Insurance Type18.104.22.168. Market Size and Forecast, by Brokerage TypeChapter 7: Company Profiles7.1. Acrisure LLC7.1.1. Company Overview7.1.2. Key Executives7.1.3. Company Snapshot7.1.4. Operating Business Segments7.1.5. Product Portfolio7.1.6. Business Performance7.1.7. Key Strategic Moves and Developments7.2. Aon plc7.2.1. Company Overview7.2.2. Key Executives7.2.3. Company Snapshot7.2.4. Operating Business Segments7.2.5. Product Portfolio7.2.6. Business Performance7.2.7. Key Strategic Moves and Developments7.3. Brown and Brown Inc7.3.1. Company Overview7.3.2. Key Executives7.3.3. Company Snapshot7.3.4. Operating Business Segments7.3.5. Product Portfolio7.3.6. Business Performance7.3.7. Key Strategic Moves and Developments7.4. Gallagher7.4.1. Company Overview7.4.2. Key Executives7.4.3. Company Snapshot7.4.4. Operating Business Segments7.4.5. Product Portfolio7.4.6. Business Performance7.4.7. Key Strategic Moves and Developments7.5. Hub International Limited7.5.1. Company Overview7.5.2. Key Executives7.5.3. Company Snapshot7.5.4. Operating Business Segments7.5.5. Product Portfolio7.5.6. Business Performance7.5.7. Key Strategic Moves and Developments7.6. Lockton Companies7.6.1. Company Overview7.6.2. Key Executives7.6.3. Company Snapshot7.6.4. Operating Business Segments7.6.5. Product Portfolio7.6.6. Business Performance7.6.7. Key Strategic Moves and Developments7.7. Marsh and Mclennan Companies Inc7.7.1. Company Overview7.7.2. Key Executives7.7.3. Company Snapshot7.7.4. Operating Business Segments7.7.5. Product Portfolio7.7.6. Business Performance7.7.7. Key Strategic Moves and Developments7.8. Truist Insurance Holdings7.8.1. Company Overview7.8.2. Key Executives7.8.3. Company Snapshot7.8.4. Operating Business Segments7.8.5. Product Portfolio7.8.6. Business Performance7.8.7. Key Strategic Moves and Developments7.9. Usi Insurance Services LLC7.9.1. Company Overview7.9.2. Key Executives7.9.3. Company Snapshot7.9.4. Operating Business Segments7.9.5. Product Portfolio7.9.6. Business Performance7.9.7. Key Strategic Moves and Developments7.10. Wills Towers Watson7.10.1. Company Overview7.10.2. Key Executives7.10.3. Company Snapshot7.10.4. Operating Business Segments7.10.5. Product Portfolio7.10.6. Business Performance7.10.7. Key Strategic Moves and DevelopmentsFor more information about this report visit https://www.researchandmarkets.com/r/3120j3 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
SHANGHAI, China, May 17, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the health and wellness market in China, announced today that on May 10, 2021, a new product, Puxue Oral Liquid, which is a supplement intended for use by children aged between one and 17, adults, pregnant women, and nursing mothers who suffer from iron and vitamin B12 deficiencies, is jointly launched by the Company and Harbin Pharmaceutical Group Co., Ltd. (“HPGC”). ECMOHO is primarily responsible for the packaging design and sales distribution of the new product. Iron and vitamin B12 deficiencies may lead to anemia, which may cause a series of health problems, including asthenia and exercise-induced asthma, as well as chronic brain hypoxia, which affects normal cognitive ability, and may negatively impact the body’s immune system. This new oral liquid supplement is designed to ameliorate iron and B12 deficiencies-induced health problems faced by many Chinese consumers. HPGC is a large medical health enterprise based in China, with six business segments which mainly cover antibiotics, OTC drugs and health products, traditional and modern Chinese medicine, biomedicine, animal vaccines and pharmaceutical business. HPGC possesses industry-leading independent R&D capabilities in medicine and health products. It is also the single largest shareholder of GNC, a well-known healthcare product retailer in the United States. Ms. Zoe Wang, Chairman and Chief Executive Officer of ECMOHO, stated: “In collaboration with HPGC, we launched this high-quality and effective iron and vitamin B12 supplement product to address the significant needs of people who suffer from symptoms caused by iron deficiency, and support their nutrition and health needs. We are pleased to partner with such a prominent company as HPGC to launch the Puxue Oral Liquid product. Our strategic cooperation demonstrates our mutual commitment to introducing new health products to address unmet needs and take advantage of the significant market opportunities in China’s health and wellness market.” About ECMOHO Ltd. ECMOHO is a leading integrated solution provider in the health and wellness market in China. The Company acts as the bridge between brand owners and Chinese consumers by marketing and distributing health supplements and food, mother and child care products, personal care products, household healthcare equipment and other health and wellness products. Through over ten years of operation, ECMOHO has built an ecosystem where Chinese consumers are provided with customized health and wellness solutions that include quality products and trustworthy content. For more information, please visit http://ir.ecmoho.com/. Safe Harbor Statements This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “going forward,” “outlook” and similar statements. Any statements that are not historical facts are forward-looking statements. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, such as the significant volatility and disruption caused by the COVID-19 pandemic, the Company’s expected growth of the online retail industry in China, the Company’s expectations regarding demand for and market acceptance of its products and services, the Company’s expectations regarding its relationships with its brand partners and e-commerce channels, and the level of consumer economic activity in China, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law. For investor and media inquiries, please contact: ECMOHO Limited Investor Relations Email: email@example.com Investor Relations Agency Contact: Skyline Corporate Communications Group, LLCLisa Gray, Senior Account ManagerOne Rockefeller Plaza, 11th FloorNew York, NY 10020Office: (646) 893-5835Email: firstname.lastname@example.org
It would also include ‘Collections’, which would let users better curate saved tweets